MedPath

Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSIL

Completed
Conditions
High-Grade Squamous Intraepithelial Lesions
Registration Number
NCT06325592
Lead Sponsor
Sichuan Cancer Hospital and Research Institute
Brief Summary

This study aimed to analyze perioperative information in patients with high-grade squamous intraepithelial lesion (HSIL) undergoing total hysterectomy (TH), offering insights into optimal surgery timing, selecting the operation path, and enhancing surgical operation details.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
826
Inclusion Criteria
  • patients were confirmed with HSIL through pathology at our hospital or another tertiary facility, with additional confirmation via pathological consultation at our facility;
  • LH or abdominal hysterectomy (AH) +/- bilateral fallopian tube or bilateral adnexectomy was performed after LEEP;
  • the patient had no history of systemic malignancies.
Exclusion Criteria
  • severe medical and surgical complications;
  • an extensive or subextensive hysterectomy was performed;
  • surgical removal scope involving tissues (such as lymph nodes) or organs (such as the appendix) other than the uterus, ovaries, and fallopian tubes;
  • fever symptoms within the last month;
  • incidence of pelvic and abdominal infections, vaginitis, or similar conditions within the past month.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative feverWithin 7 days of surgery

Use a thermometer to measure your temperature

Postoperative therapeutic use of antibioticsWithin 7 days of surgery

Postoperative therapeutic use of antibiotics

Secondary Outcome Measures
NameTimeMethod
Postoperative complicationsWithin 7 days of surgery

Postoperative complications

Postoperative hospitalization daysDate of surgery to date of discharge

Postoperative hospitalization days

Postoperative CRP valueWithin 7 days of surgery

Postoperative CRP value

Postoperative albumin numberWithin 7 days of surgery

Postoperative albumin number

Postoperative hemoglobinWithin 7 days of surgery

Postoperative hemoglobin

Postoperative erythrocyte countWithin 7 days of surgery

Postoperative erythrocyte count

Postoperative white blood cell countWithin 7 days of surgery

Postoperative white blood cell count

Trial Locations

Locations (1)

Sichuan Cancer Hospital and Research Institute

🇨🇳

Chengdu, Sichuan, China

Sichuan Cancer Hospital and Research Institute
🇨🇳Chengdu, Sichuan, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.